[FGV] YoY Annual (Unaudited) Result on 31-Dec-2017 [#4]

Stock
[FGV] FGV HOLDINGS BERHAD
Announcement Date
23-Feb-2018
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2017
Quarter
31-Dec-2017 [#4]
Profit Trend
YoY- 356.77%
Quarter Report
Latest QR
Upcoming QR
FGV's Result
FGV's Financial Summary
View:
Show?
Annual (Unaudited) Result
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Revenue 14,075,712 13,259,012 13,467,261 16,974,713 17,241,275 15,669,741 16,434,331 -2.54%
PBT 337,195 -356,657 -1,041,554 411,534 242,537 359,934 813,195 -13.63%
Tax -198,417 -14,446 -100,569 -203,488 -176,078 -47,928 -291,335 -6.19%
NP 138,778 -371,103 -1,142,123 208,046 66,459 312,006 521,860 -19.79%
-
NP to SH 150,020 -242,191 -1,079,952 143,727 31,466 117,123 306,369 -11.20%
-
Tax Rate 58.84% - - 49.45% 72.60% 13.32% 35.83% -
Total Cost 13,936,934 13,630,115 14,609,384 16,766,667 17,174,816 15,357,735 15,912,471 -2.18%
-
Net Worth 4,268,337 4,195,374 4,450,745 5,618,153 5,800,561 6,457,228 6,347,784 -6.39%
Dividend
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Div 1,094 72,963 - 182,407 - 145,926 364,815 -61.99%
Div Payout % 0.73% 0.00% - 126.91% - 124.59% 119.08% -
Equity
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Net Worth 4,268,337 4,195,374 4,450,745 5,618,153 5,800,561 6,457,228 6,347,784 -6.39%
NOSH 3,648,152 3,648,152 3,648,152 3,648,152 3,648,152 3,648,152 3,648,152 0.00%
Ratio Analysis
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
NP Margin 0.99% -2.80% -8.48% 1.23% 0.39% 1.99% 3.18% -
ROE 3.51% -5.77% -24.26% 2.56% 0.54% 1.81% 4.83% -
Per Share
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
RPS 385.83 363.44 369.15 465.30 472.60 429.53 450.48 -2.54%
EPS 4.10 -6.60 -29.60 3.90 0.90 3.20 8.40 -11.25%
DPS 0.03 2.00 0.00 5.00 0.00 4.00 10.00 -61.98%
NAPS 1.17 1.15 1.22 1.54 1.59 1.77 1.74 -6.39%
Adjusted Per Share Value based on latest NOSH - 3,648,152
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
RPS 385.83 363.44 369.15 465.30 472.60 429.53 450.48 -2.54%
EPS 4.10 -6.60 -29.60 3.90 0.90 3.20 8.40 -11.25%
DPS 0.03 2.00 0.00 5.00 0.00 4.00 10.00 -61.98%
NAPS 1.17 1.15 1.22 1.54 1.59 1.77 1.74 -6.39%
Price Multiplier on Financial Quarter End Date
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Date 31/12/20 31/12/19 31/12/18 29/12/17 30/12/16 31/12/15 31/12/14 -
Price 1.28 1.52 0.715 1.69 1.55 1.71 2.18 -
P/RPS 0.33 0.42 0.19 0.36 0.33 0.40 0.48 -6.04%
P/EPS 31.13 -22.90 -2.42 42.90 179.71 53.26 25.96 3.07%
EY 3.21 -4.37 -41.40 2.33 0.56 1.88 3.85 -2.98%
DY 0.02 1.32 0.00 2.96 0.00 2.34 4.59 -59.55%
P/NAPS 1.09 1.32 0.59 1.10 0.97 0.97 1.25 -2.25%
Price Multiplier on Announcement Date
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Date 26/02/21 28/02/20 28/02/19 23/02/18 28/02/17 29/02/16 24/02/15 -
Price 1.33 1.15 1.12 1.99 1.88 1.53 2.94 -
P/RPS 0.34 0.32 0.30 0.43 0.40 0.36 0.65 -10.22%
P/EPS 32.34 -17.32 -3.78 50.51 217.97 47.66 35.01 -1.31%
EY 3.09 -5.77 -26.43 1.98 0.46 2.10 2.86 1.29%
DY 0.02 1.74 0.00 2.51 0.00 2.61 3.40 -57.47%
P/NAPS 1.14 1.00 0.92 1.29 1.18 0.86 1.69 -6.34%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment